Unicycive Therapeutics Inc share price logo

Unicycive Therapeutics Inc Share Price

NASDAQ: UNCY

Small Cap

$7.02

+0.01

(+0.14%)

Live

as on

Unicycive Therapeutics Inc Stock Performance

as on March 18, 2026 at 3:10 am IST

  • Day's Low

    Day's High

    $6.86
    $7.09
    downward going graph

    2.28%

    Downside

    1.00%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $3.71
    $11.00
    downward going graph

    47.15%

    Downside

    56.70%

    Upside

    downward going graph

Unicycive Therapeutics Inc share price movements today

Previous Close
$7.01
Open
$7.05
Volume
187.4K
Day's Low - High
$6.86 - $7.09
52 Week Low - High
$3.71 - $11.00

Unicycive Therapeutics Inc Historical Returns

1 Month Return
+ 12.7 %
3 Month Return
+ 28.62 %
1 Year Return
+ 20.65 %
3 Year Return
-66.46 %
5 Year Return
0 %

Unicycive Therapeutics Inc Stock Fundamentals & Key Indicators

Check Unicycive Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$146.8M

EPS (TTM)

-1.2638

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-1.06

Industry PE ratio

0

PEG Ratio

0

EBITDA

-31.5M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

-102.29%

Unicycive Therapeutics Inc Stock Valuation

Track how Unicycive Therapeutics Inc P/E has moved over time to understand its valuation trends.

Unicycive Therapeutics Inc in the last 5 years

  • Overview

  • Trends

Lowest (-84.37x)

September 30, 2021

Industry (0.00x)

March 17, 2026

Today (-1.06x)

March 17, 2026

Highest (-3.43x)

September 30, 2024

LowHigh

Today’s Price to Earnings Ratio: -1.06x

Unicycive Therapeutics Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Unicycive Therapeutics Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Unicycive Therapeutics Inc image
Unicycive Therapeutics Inc
BUY$146.8MNA-1.060.00%
Alnylam Pharmaceuticals, Inc. image
Alnylam Pharmaceuticals, Inc.
BUY$41.6B119.71%135.098.45%
Vertex Pharmaceuticals Incorporated image
Vertex Pharmaceuticals Incorporated
BUY$119.2B114.71%30.6832.94%
Beone Medicines Ltd image
Beone Medicines Ltd
NA$32.8BNA1155.37%
Regeneron Pharmaceuticals, Inc. image
Regeneron Pharmaceuticals, Inc.
BUY$78.8B52.6%17.9931.41%

Stock Returns calculator for Unicycive Therapeutics Inc Stock including INR - Dollar returns

The Unicycive Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

Unicycive Therapeutics Inc investment value today

Current value as on today

₹1,27,365

Returns

₹27,365

(+27.36%)

Returns from Unicycive Therapeutics Inc Stock

₹20,826 (+20.83%)

Dollar Returns*

₹6,539 (+6.54%)

Analyst Recommendation on Unicycive Therapeutics Inc Stock

Based on 11 analysts

BUY

90.91%

Buy

9.09%

Hold

0.00%

Sell

Based on 11 analysts, 90.91% of analysts recommend a 'BUY' rating for Unicycive Therapeutics Inc. Average target price of $46.5

Unicycive Therapeutics Inc Share Price Target

Get share price movements and forecasts by analysts on Unicycive Therapeutics Inc.

What analysts predicted

84.9%UPSIDE

Target Price

$46.5

Current Price

$7.02

Analyzed by

11 Analysts

Target

$46.50

Unicycive Therapeutics Inc target price $46.5, a slight upside of 84.9% compared to current price of $7.02. According to 11 analysts rating.

Unicycive Therapeutics Inc Stock’s Investor Sentiment and Interest

Search interest for Unicycive Therapeutics Inc Stock has increased by 38% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:38% versus previous 30 day period

Unicycive Therapeutics Inc Quarterly Profit & Loss

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Total Revenue
-
-
0
-
-
-
0
-
-
-
Gross Profit
0
0
0
0
-
0
0
0
0
-
Operating Income
-4
-5
-6
-9
-7
-6
-9
-7
-6
-7
EBITDA
-3
-4
-6
-20
-7
-3
-9
0
-6
-5
Interest Expense
0
0
0
0
0
0
0
0
0
0
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-3
-4
-7
-20
9
-4
-21
0
-6
-6
Income Tax Expense
0
0
-10
0
5
-
0
-
-
-
Net Income
-3
-4
-7
-20
9
-4
-21
0
-6
-6
Net Profit Margin
0.00%
0.00%
2877.49%
0.00%
0.00%
0.00%
-3789.61%
0.00%
0.00%
0.00%

Unicycive Therapeutics Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
-
-
-
0
0
-
Gross Profit
-
-
0
0
0
0
Operating Income
-1
-2
-8
-18
-20
-32
EBITDA
-2
-2
-8
-17
-30
-36
Interest Expense
0
0
0
0
0
0
Depreciation
-
-
0
0
0
0
Income Before Tax
-2
-2
-10
-18
-30
-36
Income Tax Expense
0
0
0
0
0
-1
Net Income
-2
-2
-10
-18
-30
-36
Net Profit Margin
0.00%
0.00%
0.00%
-1899.47%
-4525.04%
0.00%

Unicycive Therapeutics Inc Quarterly Cash Flow

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Net Income
-4
-7
-20
9
-4
-21
0
-6
-6
Operating Cash Flow
-4
-4
-6
-6
-9
-6
-8
-8
-5
Investing Cash Flow
-
-
0
0
0
0
0
0
0
Financing Cash Flow
0
0
45
0
0
0
2
10
26
Change in Cash
-4
-4
39
-7
-9
-6
-6
2
20

Unicycive Therapeutics Inc Annual Cash Flow

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Net Income
-2
-2
-10
-18
-30
-36
Operating Cash Flow
-1
-1
-5
-15
-18
-28
Investing Cash Flow
0
0
0
0
0
0
Financing Cash Flow
1
1
22
0
27
45
Change in Cash
0
0
16
-16
9
16

Global Institutional Holdings in Unicycive Therapeutics Inc

Funds
Holdings
Dauntless Investment Group, LLC
0.74%
The Goldman Sachs Group Inc
0.37%
Quadrature Capital Limited
0.32%
XTX Topco Ltd
0.31%
Renaissance Technologies Corp
0.07%
See all

Insights on Unicycive Therapeutics Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, -271.0K → 568.0K (in $), with an average increase of 147.7% per quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 3 months, UNCY stock has moved up by 28.6%

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, -6.44M → -6.01M (in $), with an average increase of 7.3% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 26.0% return, outperforming this stock by 5.3%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 72.0% return, outperforming this stock by 138.5%

About Unicycive Therapeutics Inc

unicycive therapeutics is passionate about treating kidney diseases with significant unmet medical needs.
OrganisationUnicycive Therapeutics Inc
Headquarters4300 El Camino Real, Los Altos, CA, United States, 94022
CEODr. Shalabh K. Gupta M.D., MPA
E-voting on sharesClick here to vote

Key Management of Unicycive Therapeutics Inc

Name

Title

Mr. Douglas Jermasek M.B.A.

Executive Vice President of Corporate Strategy

Mr. John W. Townsend CPA

Chief Financial Officer

Dr. Shalabh K. Gupta M.D., MPA

Founder, Chairman, CEO & President

Dr. Pramod Gupta Ph.D.

Executive Vice President of Operations

FAQs

What is Unicycive Therapeutics Inc share price today?

Unicycive Therapeutics Inc share price today is $7.02 as on . Unicycive Therapeutics Inc share today touched a day high of $7.09 and a low of $6.86.

What is the 52 week high and 52 week low for Unicycive Therapeutics Inc share?

Unicycive Therapeutics Inc share touched a 52 week high of $11 on and a 52 week low of $3.71 on . Unicycive Therapeutics Inc stock price today i.e. is trending at $7.02,which is 36.18% down from its 52 week high and 89.22% up from its 52 week low.

What is Unicycive Therapeutics Inc's market capitalisation today?

Unicycive Therapeutics Inc market capitalisation is $0.00T as on .

How to invest in Unicycive Therapeutics Inc Stock (UNCY) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Unicycive Therapeutics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Unicycive Therapeutics Inc Shares that will get you 0.2137 shares as per Unicycive Therapeutics Inc share price of $7.02 per share as on March 17, 2026 at 9:40 pm IST.

What is the minimum amount required to buy Unicycive Therapeutics Inc Stock (UNCY) from India?

Indian investors can start investing in Unicycive Therapeutics Inc (UNCY) shares with as little as ₹92.369 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹923.69 in Unicycive Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Unicycive Therapeutics Inc share’s latest price of $7.02 as on March 17, 2026 at 9:40 pm IST, you will get 1.4245 shares of Unicycive Therapeutics Inc. Learn more about fractional shares .